Kenry, PhD

Kenry, PhD

Assistant Professor

Kenry joined the Department of Pharmacology and Toxicology at the University of Arizona as an Assistant Professor in Pharmaceutical Sciences in June 2023. Prior to that, he conducted his postdoctoral work at Harvard University, Dana-Farber Cancer Institute, the University of British Columbia, and the National University of Singapore. Kenry received his PhD in Biomedical Engineering from the National University of Singapore and BEng (Electrical and Electronic Engineering) with First Class Honors from Nanyang Technological University, Singapore.

The Kenry Lab at the University of Arizona seeks to improve patient outcome and health by addressing various unmet needs in cancer diagnosis and treatment. Leveraging its expertise in nanomaterials, microfluidics, bioimaging, immunotherapy, and machine learning, the Kenry Lab adopts bioinspired and data-driven approaches to build novel micro/nanoscale platform tools and models to enable more personalized, targeted, and safer detection and treatment of cancer.
 

Post Graduate Training

Postdoc, Immunotherapy and Machine Learning, Harvard University, 2020–2023
Postdoc, Bioimaging and Nanomedicine, Dana-Farber Cancer Institute/Harvard Medical School, 2019–2023
Postdoc, Pharmaceutical Sciences, University of British Columbia, Canada, 2019
Postdoc, Bioimaging and Nanomedicine, National University of Singapore, Singapore, 2017–2019

 

Areas of Research

Nanomedicine
Immunotherapy
Bioimaging
Microfluidics
Artificial Intelligence and Machine Learning

Degree(s)

  • PhD, Biomedical Engineering, National University of Singapore, Singapore, 2017
  • BEng, Electrical and Electronic Engineering, Nanyang Technological University, Singapore, 2011